These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22999714)

  • 1. Basic principles of tumor-associated regulatory T cell biology.
    Savage PA; Malchow S; Leventhal DS
    Trends Immunol; 2013 Jan; 34(1):33-40. PubMed ID: 22999714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced regulatory T cells in inhibitory microenvironments created by cancer.
    Whiteside TL
    Expert Opin Biol Ther; 2014 Oct; 14(10):1411-25. PubMed ID: 24934899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy.
    Munn DH; Sharma MD; Johnson TS
    Cancer Res; 2018 Sep; 78(18):5191-5199. PubMed ID: 30181177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
    Sasidharan Nair V; Elkord E
    Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
    Campbell JR; McDonald BR; Mesko PB; Siemers NO; Singh PB; Selby M; Sproul TW; Korman AJ; Vlach LM; Houser J; Sambanthamoorthy S; Lu K; Hatcher SV; Lohre J; Jain R; Lan RY
    Cancer Res; 2021 Jun; 81(11):2983-2994. PubMed ID: 33757978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of costimulatory and inhibitory receptors in FoxP3
    Toker A; Ohashi PS
    Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancers.
    Knutson KL
    Future Oncol; 2006 Jun; 2(3):379-89. PubMed ID: 16787118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.
    Nishikawa H; Koyama S
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and clinical observations of regulatory T cells in cancer immunology.
    Teng MW; Ritchie DS; Neeson P; Smyth MJ
    Curr Top Microbiol Immunol; 2011; 344():61-95. PubMed ID: 20512555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
    Kochin V; Nishikawa H
    Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T Cells in the Tumor Microenvironment.
    Dadey RE; Workman CJ; Vignali DAA
    Adv Exp Med Biol; 2020; 1273():105-134. PubMed ID: 33119878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tregs and rethinking cancer immunotherapy.
    Curiel TJ
    J Clin Invest; 2007 May; 117(5):1167-74. PubMed ID: 17476346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy.
    Yan S; Zhang Y; Sun B
    Sci China Life Sci; 2019 Feb; 62(2):179-186. PubMed ID: 30610537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.
    Chaudhary B; Abd Al Samid M; al-Ramadi BK; Elkord E
    Expert Opin Biol Ther; 2014 Jul; 14(7):931-45. PubMed ID: 24661020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic depletion of CCR8
    Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines.
    Ruter J; Barnett BG; Kryczek I; Brumlik MJ; Daniel BJ; Coukos G; Zou W; Curiel TJ
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1761-70. PubMed ID: 19273160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
    Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
    J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective.
    Le DT; Jaffee EM
    Cancer Res; 2012 Jul; 72(14):3439-44. PubMed ID: 22761338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.